2m 2m 2m 2m 2m 2m 2m
Panacea Life Sci (PLSH)
OTC
$0.08+$0.01 (+20.69%)
Price as of Oct 21, 2026- N/AMarket Cap
- 20.00%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Panacea Life Sci (PLSH)
$0.08+$0.01 (+20.69%)
PLSH | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.08 | ||
Change | +$0.01 (+20.69%) | ||
Open | $0.07 | ||
High | $0.08 | ||
Low | $0.07 | ||
Previous Close | $0.07 | ||
Volume | 200 | ||
30-Day Average Volume | 3,239 | ||
1-Week Change | 27.27% | ||
1-Month Change | -1.18% | ||
1-Year Change | 20.00% | ||
3-Year Change | -69.89% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 20.8M | ||
Total Assets | $17.4M | ||
Market Cap | N/A | ||
Enterprise Value | N/A | ||
Period: QTR TTM FY | |||
Revenue | $1.1M | ||
Net Income | -$1.4M | ||
Free Cash Flow | -$362,090.00 | ||
EBIT | -$1.0M | ||
EBITDA | -$632,904.00 | ||
Net Working Capital | -$15.7M | ||
EPS | -$0.09 | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | -0 | ||
P/E | -1 | ||
PEG | -0 | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 20 : 1 | ||
Last Split Date | 12/28/2016 | ||